The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 05, 2018
Filed:
Jul. 18, 2014
Green Cross Corporation, Yongin-si, Gyeonggi-do, KR;
Legochem Biosciences,inc., Daejeon, KR;
Soongyu Choi, Yongin-si, KR;
Jungsub Choi, Yongin-si, KR;
So-Hyun Yoon, Yongin-si, KR;
Yoo Hoon Kim, Yongin-si, KR;
Jae Yeon Kim, Yongin-si, KR;
Suk Ho Lee, Yongin-si, KR;
Young Lag Cho, Daejeon, KR;
Ho Young Song, Daejeon, KR;
Dae Yon Lee, Daejeon, KR;
Sung Yoon Baek, Daejeon, KR;
Sang Eun Chae, Daejeon, KR;
Tae Kyo Park, Daejeon, KR;
Sung Ho Woo, Daejeon, KR;
Yong Zu Kim, Daejeon, KR;
GREEN CROSS CORPORATION, Yongin-si, KR;
LEGOCHEM BIOSCIENCES, INC., Daejeon, KR;
Abstract
The present invention relates to a novel crystalline form of 5-chloro-N-({(5S)-2-oxo-3-[4-(5,6-dihydro-4H-[1,2,4]triazin-1-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide methanesulfonate and a pharmaceutical composition containing the same. The novel crystalline form of a compound according to the present invention exhibits excellent stability even in high-temperature and humidity environments, and thus can be favorably used to prevent or treat diseases, such as thrombosis, myocardial infarction, atherosclerosis, inflammation, stroke, angina pectoris, restenosis after angioplasty, and thromboembolism.